Tjellesen Max Jenne (TMJ) is a Danish pharmaceutical wholesaler and distributor with a focus on supply and patient safety through logistics and service solutions for pharmacies, hospitals, and the pharmaceutical industry. With over 110 years of knowledge and experience, TMJ prides itself on being an essential link in the supply chain of pharmaceuticals, ensuring the highest level of product integrity through a strong supply chain, solid infrastructure, and leading logistics technology. The company's strong emphasis on supply and patient safety, along with its commitment to providing the best service solutions and concepts, reflects its dedication to ensuring the well-being of Danish families and patients. TMJ's partnership approach enables the delivery of medications, pharmacy-related OTC products, and medical equipment to pharmacies and hospital pharmacies, ultimately benefiting the Danish population. TMJ is backed by the investment fund Erhvervsinvest, which was established in 2004 and focuses on investing in well-established and healthy Danish-based companies with potential for further growth and development. This partnership with Erhvervsinvest provides TMJ with the support and resources to continue its mission of enhancing supply chain efficiency and ensuring the availability of medications where and when they are needed. Overall, TMJ's dedication to supply chain integrity, patient safety, and innovative service solutions, combined with the backing of a reputable investment fund, positions the company for continued growth and success within the pharmaceutical and retail industries.
There is no investment information
No recent news or press coverage available for Tjellesen Max Jenne.